Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
Advances in Therapy
|
September 6, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
Uma Borate, Karen Seiter, Ravi Potluri, et al.
Leukemia & Lymphoma
|
November 28, 2024
Oral azacitidine maintenance after intensive chemotherapy versus venetoclax and azacitidine: real world outcomes in newly diagnosed acute myeloid leukemia
Alice Mims, Zhuoer Xie, Ravi Potluri, et al.
American Journal of Hematology
|
March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia
Nathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
Leukemia & Lymphoma
|
December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia
Norbert Vey, Thomas Prebet, Claire Thalamas, et al.
Oncotarget
|
June 17, 2014
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL
Marie Loosveld, Rémy Castellano, Stéphanie Gon, et al.
Leukemia & Lymphoma
|
December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis
Jennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Annals of Hematology
|
February 2, 2023
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
Amer M Zeidan, Daniel A Pollyea, Uma Borate, et al.
Oncotarget
|
February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
Thomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
Advances in Therapy
|
September 6, 2024
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
Uma Borate, Karen Seiter, Ravi Potluri, et al.
Leukemia & Lymphoma
|
November 28, 2024
Oral azacitidine maintenance after intensive chemotherapy versus venetoclax and azacitidine: real world outcomes in newly diagnosed acute myeloid leukemia
Alice Mims, Zhuoer Xie, Ravi Potluri, et al.
American Journal of Hematology
|
March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia
Nathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
Leukemia & Lymphoma
|
December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia
Norbert Vey, Thomas Prebet, Claire Thalamas, et al.
Oncotarget
|
June 17, 2014
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL
Marie Loosveld, Rémy Castellano, Stéphanie Gon, et al.
Leukemia & Lymphoma
|
December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis
Jennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Annals of Hematology
|
February 2, 2023
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
Amer M Zeidan, Daniel A Pollyea, Uma Borate, et al.
Oncotarget
|
February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
Thomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
Page
of 10